16 Results for "

Negative control probe

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "Negative control probe" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-100729
CAS No.: 1923851-49-3
Purity:  99.52%
Research Areas:  

Cancer

GSK9311, a less active analogue of GSK6853, can be used as a negative control. GSK9311 inhibits BRPF bromodomain with pIC50 values of 6.0 and 4.3 for BRPF1 and BRPF2, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101027A
CAS No.: 2079886-19-2
Purity:  98.06%
GSK4028 is the enantiomeric negative control of GSK4027, which is a PCAF/GCN5 bromodomain chemical probe, the pIC50 of GSK4028 is 4.9 in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay.
loading...
    loading...
Cat. No.: HY-139174
CAS No.: 2301865-01-8
Target:  

MAGL

Research Areas:  

Inflammation/Immunology

(S)-DO271 is a non-active control probe targeting ABHD12, and it has almost no inhibitory activity against ABHD12 (IC50 > 100 μM). (S)-DO271 does not cause the upregulation of inflammatory factors and has no cytotoxicity. (S)-DO271 is suitable as a negative control for validating the functional studies of ABHD12 .
loading...
    loading...
Cat. No.: HY-114163A
CAS No.: 2985948-67-0
Research Areas:  

Others

rel-ML123 is a negative control probe of ML123 (trans-Racemate) (HY-114163) .
loading...
    loading...
Cat. No.: HY-136192
CAS No.: 2080306-24-5
Research Areas:  

Cancer

TP-472N is a negative control probe for TP-472. TP-472 is a potent and selective BRD7/9 probe .
loading...
    loading...
Cat. No.: HY-156965
CAS No.: 2771756-82-0
Target:  

Fluorescent Dye

Research Areas:  

Metabolic Disease Cancer

BAY-771, a structurally close pyrimidinedione, is a chemical probe with good lead-like properties and high permeability in Caco-2 cells (no hint of efflux). BAY-771 shows very weak inhibitory activity in the BCAT1 biochemical assay and no activity in BCAT2. BAY-771 can be used as a negative control of HY-148242 BAY-069. BAY-771 can be used for the research of tumor metabolism .
loading...
    loading...
Cat. No.: HY-100729A
CAS No.: 2253733-09-2
Research Areas:  

Cancer

GSK9311 hydrochloride, a less active analogue of GSK6853, can be used as a negative control. GSK9311 hydrochloride inhibits BRPF bromodomain with pIC50 values of 6.0 and 4.3 for BRPF1 and BRPF2, respectively .
loading...
    loading...
Cat. No.: HY-130676
CAS No.: 2561494-73-1
Target:  

CDK

Research Areas:  

Cancer

CLK-IN-T3N, the negative control of CLK-IN-T3 (HY-115470), is a chemical probe for CDC-like kinase (CLK).
loading...
    loading...
Cat. No.: HY-175343A
Target:  

Ligands for E3 Ligase

Research Areas:  

Infection

OICR-41103N is the negative control form of OICR-41103 (HY-175343). OICR-41103 is an effective, selective, cell-active DCAF1 small molecule chemical probe (Ki<2 nM) that targets the DCAF1 WDR domain and replaces the viral Vpr protein .
loading...
    loading...
Cat. No.: HY-100729R
CAS No.: 1923851-49-3
Research Areas:  

Cancer

GSK9311 (Standard) is the analytical standard of GSK9311 (HY-100729). This product is intended for research and analytical applications. GSK9311, a less active analogue of GSK6853, can be used as a negative control. GSK9311 inhibits BRPF bromodomain with pIC50 values of 6.0 and 4.3 for BRPF1 and BRPF2, respectively .
loading...
    loading...
Cat. No.: HY-184153
Target:  

Drug Isomer

Research Areas:  

Others

IMP-2958 is an inactive enantiomeric negative control probe with significantly reduced binding to RAB27A/B-Cys123.IMP-2958 serves as a negative control probe for off-target binding in phenotypic assays related to RAB27A/B studies.IMP-2958 functions as a control for stereoselective targeted covalent inhibitors of the RAB27-effector protein-protein interaction .
loading...
    loading...
Cat. No.: HY-101027AR
CAS No.: 2079886-19-2
GSK4028 (Standard) is the analytical standard of GSK4028 (HY-101027A). This product is intended for research and analytical applications. GSK4028 is the enantiomeric negative control of GSK4027, which is a PCAF/GCN5 bromodomain chemical probe, the pIC50 of GSK4028 is 4.9 in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay.
loading...
    loading...
Cat. No.: HY-184012
Target:  

Phospholipase

Research Areas:  

Endocrinology

BAY-163 is a tertiary urea derivative and inactive negative control probe for BAY-439 (HY-178123). BAY-163 does not inhibit phospholipase A2 group V (PLA2-G5) activity in immune cells. BAY-163 can be used for research on endometriosis .
loading...
    loading...
Cat. No.: HY-183468
CAS No.: 945611-89-2
Research Areas:  

Others

MV152 serves as the inactive control for the proteasome activity probe MV151. It contains a reduced ethyl sulfone group that replaces the vinyl sulfone reactive group of MV151, while retaining the identical fluorescent reporter group and peptide recognition sequence. MV152 does not bind to the active site of the proteasomal catalytic subunit β, does not induce peptide-mediated elevation of 20S proteasome activity, and does not label the proteasomal catalytic subunit β in brain tissue homogenates. MV152 can be used as an inactive negative control in proteasome-related experiments .
loading...
    loading...
Cat. No.: HY-181421
CAS No.: 2929223-36-7
Target:  

SF3B1

Research Areas:  

Cancer

WX-02-43 is a weak covalent inhibitor of SF3B1, and is the (1S,3R) enantiomer of WX-02-23 (HY-168534). WX-02-43 cannot effectively covalently modify the C258 site in the DNA-binding domain of FOXA1, and its inhibitory activity against SF3B1 is also weaker than that of WX-02-23. WX-02-43 serves as a negative control probe that fails to remodel the chromatin binding pattern and transcriptional activity of FOXA1. WX-02-43 can be used in studies on cancers such as prostate cancer to verify the specific effects of WX-02-23 on FOXA1 and SF3B1 targets .
loading...
    loading...
Cat. No.: HY-18542
CAS No.: 1402612-58-1
KT195 is a serine hydrolase inhibitor that targets ABHD6 (IC50 = 10 nM) and ABHD2, with no significant activity against DAGLβ. KT195 inhibits endoplasmic reticulum calcium release and mitochondrial calcium uptake by targeting ABHD2, thereby blocking A23187 (HY-N6687) and H2O2-induced necrotic cell death and apoptosis. By inhibiting ABHD6 activity, KT195 significantly induces 2-AG accumulation in Neuro2A cells and reduces IL-1β secretion in lipopolysaccharide-treated macrophages. KT195 has been used as a negative control probe for DAGLβ and can be applied in studies of ABHD6 and ABHD2 in calcium signaling, lipid metabolism, neuronal function, and inflammatory .
loading...
    loading...
  • 1